Despite its promise, cancer genomics faces several challenges. These include the genetic heterogeneity of tumors, which means that different cells within the same tumor can have different mutations, and the complexity of distinguishing driver mutations from passenger mutations. Additionally, the high cost and technical demands of genomic sequencing technologies can be barriers to widespread implementation.
